These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34962752)
1. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy. Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752 [TBL] [Abstract][Full Text] [Related]
2. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Wang J; Jia J; Liu J; He H; Zhang W; Li Z Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327 [TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase. He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440 [TBL] [Abstract][Full Text] [Related]
4. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells. Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting. Hu Y; Zou J; Wang Q; Chen Y; Wang H; Li J Eur J Pharm Biopharm; 2024 Mar; 196():114184. PubMed ID: 38244896 [TBL] [Abstract][Full Text] [Related]
6. Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein. He H; Zhang M; Liu L; Zhang S; Liu J; Zhang W Pharm Res; 2015 Oct; 32(10):3415-31. PubMed ID: 26040661 [TBL] [Abstract][Full Text] [Related]
7. Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction. Parks JS; Gebre AK J Lipid Res; 1997 Feb; 38(2):266-75. PubMed ID: 9162746 [TBL] [Abstract][Full Text] [Related]
8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins. Jia J; Xiao Y; Liu J; Zhang W; He H; Chen L; Zhang M J Pharm Sci; 2012 Aug; 101(8):2900-8. PubMed ID: 22628199 [TBL] [Abstract][Full Text] [Related]
10. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their lipid but not apolipoprotein composition. Bolin DJ; Jonas A J Biol Chem; 1994 Mar; 269(10):7429-34. PubMed ID: 8125962 [TBL] [Abstract][Full Text] [Related]
11. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. Cho KH; Durbin DM; Jonas A J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750 [TBL] [Abstract][Full Text] [Related]
12. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase. Durbin DM; Jonas A J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955 [TBL] [Abstract][Full Text] [Related]
13. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase. Liang HQ; Rye KA; Barter PJ J Lipid Res; 1996 Sep; 37(9):1962-70. PubMed ID: 8895062 [TBL] [Abstract][Full Text] [Related]
14. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys. Thornburg JT; Parks JS; Rudel LL J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Zhang W; He H; Liu J; Wang J; Zhang S; Zhang S; Wu Z Biomaterials; 2013 Jan; 34(1):306-19. PubMed ID: 23069716 [TBL] [Abstract][Full Text] [Related]
16. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy. Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079 [TBL] [Abstract][Full Text] [Related]
17. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. Bolin DJ; Jonas A J Biol Chem; 1996 Aug; 271(32):19152-8. PubMed ID: 8702592 [TBL] [Abstract][Full Text] [Related]
18. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. Clay MA; Pyle DH; Rye KA; Barter PJ J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751 [TBL] [Abstract][Full Text] [Related]
20. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]